Thomas R Cannell - Net Worth and Insider Trading
Thomas R Cannell Net Worth
The estimated net worth of Thomas R Cannell is at least $21,140 dollars as of 2024-10-05. Thomas R Cannell is the President and CEO of Sesen Bio Inc and owns about 33,619 shares of Sesen Bio Inc (SESN) stock worth over $21,140. Details can be seen in Thomas R Cannell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas R Cannell has not made any transactions after 2023-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas R Cannell
Thomas R Cannell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas R Cannell owns 3 companies in total, including Sesen Bio Inc (SESN) , Orexigen Therapeutics Inc (OREXQ) , and CARISMA Therapeutics Inc (CARM) .
Click here to see the complete history of Thomas R Cannell’s form 4 insider trades.
Insider Ownership Summary of Thomas R Cannell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SESN | Sesen Bio Inc | 2023-03-02 | director & President and CEO |
| OREXQ | Orexigen Therapeutics Inc | 2017-10-13 | EVP & COO & Pres Global Com Prod |
| CARM | CARISMA Therapeutics Inc | 2019-02-21 | director & President and CEO |
Thomas R Cannell Latest Holdings Summary
Thomas R Cannell currently owns a total of 1 stock. Thomas R Cannell owns 33,619 shares of Sesen Bio Inc (SESN) as of March 2, 2023, with a value of $21,140.
Latest Holdings of Thomas R Cannell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SESN | Sesen Bio Inc | 2023-03-02 | 33,619 | 0.63 | 21,140 |
Holding Weightings of Thomas R Cannell
Thomas R Cannell Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas R Cannell has made a total of 2 transactions in Sesen Bio Inc (SESN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sesen Bio Inc is the sale of 24,374 shares on March 2, 2023, which brought Thomas R Cannell around $287,617.
Insider Trading History of Thomas R Cannell
- 1
Thomas R Cannell Trading Performance
Thomas R Cannell Ownership Network
Thomas R Cannell Owned Company Details
What does Sesen Bio Inc do?
Who are the key executives at Sesen Bio Inc?
Thomas R Cannell is the director & President and CEO of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , Chief Scientific Officer Michael Klichinsky , and director & President and CEO Steven Kelly .
Sesen Bio Inc (SESN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sesen Bio Inc Insider Transactions
Thomas R Cannell Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas R Cannell. You might contact Thomas R Cannell via mailing address: C/o Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
